journal article·2020-06-10

Tumor-Cell-Surface Adherable Peptide-Drug Conjugate Prodrug Nanoparticles Inhibit Tumor Metastasis and Augment Treatment Efficacy

Chen Qian, Jingjing Wang, Ying Qian, Rongfeng Hu, Jiayu Zou, Chenqi Zhu, Yuan Zhu, Shuyang Qi, Xiaobin Jia, Li Wu, Weidong Li, Zhipeng Chen

Nano Letters· Volume 20· Issue 6
Publisher page

Abstract

Cancer metastasis is the main cause of chemotherapeutic failure. Inhibiting the activity of matrix metalloproteinases (MMPs) is a common strategy for reducing metastasis. However, broad-spectrum MMP-inhibitors (MMPI) may cause undesired side effects. Here, we screened a selective MMP2 inhibitor (CCKIGLFRWR) and linked it with doxorubicin (DOX) to produce an amphiphilic peptide-drug conjugate (PDC). Then novel core-shell nanoparticles were self-assembled from PDC core and modified polylysine (MPL) shell. When the particles were passively targeted to the tumor site, the PDC core was exposed for charge switch of the MPL shell, aggregated for its transformation behavior, and specially adhered to the cell membrane. The disulfide bond between the MMPI peptide and DOX was broken via a low concentration of glutathione-mediated reduction in tumor microenvironment. DOX could effectively enter the tumor cells. Meanwhile, the MMPI peptide could selectively inhibit the activity of the MMP2 and effectively inhibit tumor metastasis.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Peptidase Inhibition and Analysis · Nanoparticle-Based Drug Delivery · Protease and Inhibitor Mechanisms

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China

Key Laboratory of Xin’an Medicine, Ministry of Education, Anhui Province Key Laboratory of R&D of Chinese Medicine, Anhui University of Chinese Medicine, Hefei, Anhui 230038, China

Department of Pharmacy, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou 215002, China

School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China

Funding

Ministry of Science and Technology of the People's Republic of China · Nanjing University of Chinese Medicine · Jiangsu Provincial Department of Education · National Natural Science Foundation of China · Suzhou Science and Technology Development Plan · State Key Laboratory of Natural Medicines, China Pharmaceutical University · Jiangsu Provincial Key Laboratory of Chinese Medicine Processing, Nanjing University of Chinese Medicine

References (46)

Show source-provided references
1. 10.1038/nrc.2018.1510.1038/nrc.2018.15 ↗
2. 10.1182/blood-2006-02-00536310.1182/blood-2006-02-005363 ↗
3. 10.1016/j.jaut.2009.09.01110.1016/j.jaut.2009.09.011 ↗
4. 10.1111/jpi.1230810.1111/jpi.12308 ↗
5. 10.1172/JCI3377510.1172/JCI33775 ↗
6. 10.1023/B:HREV.0000011395.11179.af10.1023/B:HREV.0000011395.11179.af ↗
7. 10.1158/1078-0432.CCR-1183-0210.1158/1078-0432.CCR-1183-02 ↗
8. 10.5483/BMBRep.2007.40.6.106910.5483/BMBRep.2007.40.6.1069 ↗
9. 10.1016/j.bbagen.2012.07.01310.1016/j.bbagen.2012.07.013 ↗
10. 10.1016/S1470-2045(06)70677-510.1016/S1470-2045(06)70677-5 ↗
11. 10.1038/srep2219810.1038/srep22198 ↗
12. 10.1158/1535-7163.MCT-17-064610.1158/1535-7163.MCT-17-0646 ↗
13. 10.1016/j.bmcl.2016.03.06410.1016/j.bmcl.2016.03.064 ↗
14. 10.1186/s13046-017-0633-y10.1186/s13046-017-0633-y ↗
15. 10.1007/s13402-015-0251-710.1007/s13402-015-0251-7 ↗
16. 10.3390/cancers402032310.3390/cancers4020323 ↗
17. 10.1002/adfm.20180605810.1002/adfm.201806058 ↗
18. 10.1002/advs.20190143010.1002/advs.201901430 ↗
19. 10.1186/s12935-014-0099-310.1186/s12935-014-0099-3 ↗
20. 10.1038/nrc74510.1038/nrc745 ↗
21. 10.1038/nrc88410.1038/nrc884 ↗
22. 10.2174/092986704336401810.2174/0929867043364018 ↗
23. 10.1016/j.bmc.2007.01.01110.1016/j.bmc.2007.01.011 ↗
24. 10.1002/ddr.2103810.1002/ddr.21038 ↗
25. 10.1074/jbc.M30113920010.1074/jbc.M301139200 ↗
26. 10.1074/jbc.M50430320010.1074/jbc.M504303200 ↗
27. 10.1016/j.bmc.2015.09.01310.1016/j.bmc.2015.09.013 ↗
28. 10.2174/138161205338211510.2174/1381612053382115 ↗
29. 10.1021/acsnano.8b0605810.1021/acsnano.8b06058 ↗
30. 10.1002/ange.20090721010.1002/ange.200907210 ↗
31. 10.1080/1061186X.2017.130904410.1080/1061186X.2017.1309044 ↗
32. 10.1002/pro.339410.1002/pro.3394 ↗
33. 10.1021/jp102744g10.1021/jp102744g ↗
34. 10.1039/C8CP03316A10.1039/C8CP03316A ↗
35. 10.1002/anie.20180971610.1002/anie.201809716 ↗
36. 10.1021/acsnano.7b0078110.1021/acsnano.7b00781 ↗
37. 10.1002/adma.20180717510.1002/adma.201807175 ↗
38. 10.1016/j.yexcr.2012.12.01710.1016/j.yexcr.2012.12.017 ↗
39. 10.1007/s10856-012-4555-010.1007/s10856-012-4555-0 ↗
40. 10.1016/j.cell.2010.03.01510.1016/j.cell.2010.03.015 ↗
41. 10.1016/j.ejmech.2018.10.04210.1016/j.ejmech.2018.10.042 ↗
42. 10.1002/ijc.1116810.1002/ijc.11168 ↗
43. 10.1016/j.yexcr.2018.03.03610.1016/j.yexcr.2018.03.036 ↗
44. 10.1007/s00018-008-8281-110.1007/s00018-008-8281-1 ↗
45. 10.1016/bs.pmbts.2017.04.00310.1016/bs.pmbts.2017.04.003 ↗
46. 10.1016/j.bbamcr.2009.08.00610.1016/j.bbamcr.2009.08.006 ↗